Canadian Canagliflozin Registry: A Prospective, 12-Month Observational Study of Canagliflozin Treatment in Type 2 Diabetes Mellitus: Achievement of the Triple Composite Endpoint and Low Incidence of Severe Hypoglycemia

Harpreet Bajaj; Maureen Clement; Vincent Woo; Fernando Camacho; Natasha Georgijev; Jennifer Rose; Wally Rapattoni; Alan Bell

首页> 外文期刊>Canadian journal of diabetes >Canadian Canagliflozin Registry: A Prospective, 12-Month Observational Study of Canagliflozin Treatment in Type 2 Diabetes Mellitus: Achievement of the Triple Composite Endpoint and Low Incidence of Severe Hypoglycemia

【24h】

Canadian Canagliflozin Registry: A Prospective, 12-Month Observational Study of Canagliflozin Treatment in Type 2 Diabetes Mellitus: Achievement of the Triple Composite Endpoint and Low Incidence of Severe Hypoglycemia

机译：加拿大苍珠红素注册处：一项前瞻性，12个月的甲虫杆菌治疗观测研究2型糖尿病：成就三重复合终点和严重低血基血症的发病率低

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Canadian journal of diabetes》 |2018年第5期|共2页
作者
Harpreet Bajaj; Maureen Clement; Vincent Woo; Fernando Camacho; Natasha Georgijev; Jennifer Rose; Wally Rapattoni; Alan Bell;
展开▼
作者单位

Brampton ON;

Brampton ON;

Brampton ON;

Brampton ON;

Brampton ON;

Brampton ON;

Brampton ON;

Brampton ON;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献

1. Canadian Canagliflozin Registry: A Prospective, 12-Month Observational Study of Canagliflozin Treatment in Type 2 Diabetes Mellitus: Achievement of the Triple Composite Endpoint and Low Incidence of Severe Hypoglycemia [J] . Harpreet Bajaj, Maureen Clement, Vincent Woo, Canadian journal of diabetes . 2018,第5期

机译：加拿大苍珠红素注册处：一项前瞻性，12个月的甲虫杆菌治疗观测研究2型糖尿病：成就三重复合终点和严重低血基血症的发病率低
2. Canadian Canagliflozin Registry: Prospective, Observational Assessment of Canagliflozin Treatment in Type 2 Diabetes Mellitus; 12 Month Results [J] . Maureen Clement, Alan Bell, Vincent Woo, Canadian journal of diabetes . 2018,第5期

机译：加拿大加拿大苍珠红素注册机构：甲虫三唑唑氏菌甲状腺肿甲虫治疗的前瞻性，观察评估; 12个月的结果
3. CANadian CAnagliflozin REgistry (CanCARE) – A Prospective, Observational, Assessment of Canagliflozin Treatment in Type 2 Diabetes Mellitus (T2DM); Six Month Results [J] . Vincent Woo, Harpreet S. Bajaj, Alan Bell, Canadian journal of diabetes . 2017,第Speca期

机译：加拿大加拿大甲虫利比洛兹州注册处（vinalare） - 甲虫卵尿嘧啶（T2DM）中的蜜饯，甲虫唑唑唑治疗的前瞻性，观察性评估; 六个月的结果
4. CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice [O] . Vincent Woo, Alan Bell, Maureen Clement, -1

机译：加拿大卡那列净治疗：加拿大临床实践中卡那列净治疗2型糖尿病的有效性和安全性
5. CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice [O] . Vincent Woo, Alan Bell, Maureen Clement, 2018

机译：加拿大苍珠红素注册表：羊皮脂素在加拿大临床实践中治疗2型糖尿病的疗效和安全性

Canadian Canagliflozin Registry: A Prospective, 12-Month Observational Study of Canagliflozin Treatment in Type 2 Diabetes Mellitus: Achievement of the Triple Composite Endpoint and Low Incidence of Severe Hypoglycemia

著录项

相似文献

相关主题

期刊订阅